The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
Frontiers in Microbiology · 09.07.2025 · 16
DOI: 10.3389/fmicb.2025.1535356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.07.2025. Verfasst von Jue Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, People's Hospital of Liyang, Liyang, China. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut-brain-kidney axis represents a dynamic interplay among the gut microbiota, renal function, and neurological processes, emerging as a critical factor in chronic kidney disease (CKD) pathophysiology. This paper reviews recent data on the mechanisms and pathways that integrate gut-brain-kidney signaling and communication, advances in our understanding of this axis, and potential diagnostic and prognostic biomarkers and interventions for CKD. Literature search was conducted on PubMed, Scopus, Web of Science, and Embase using a combination of the keywords gut microbiota, gut microbiome, gut-brain axis, gut-kidney axis, gut-brain-kidney axis, chronic kidney disease, dysbiosis, therapy, metabolites, and neuroinflammation.” Relevant studies were selected and synthesized in this narrative review. Gut dysbiosis, characterized by microbial composition and function alterations, contributes to systemic inflammation and metabolic imbalances, exacerbating CKD progression. Uremic toxins such as indoxyl sulfate and p-cresyl sulfate, derived from microbial metabolism, impair kidney function and disrupt neurocognitive health via oxidative stress and neuroinflammation, highlighting the interconnectedness of these systems. Recent advances in high-throughput sequencing and metabolomics have elucidated mechanisms linking gut microbiota and associated metabolites to kidney and brain health, revealing the role of microbial diversity and metabolite profiles in disease outcomes. Studies demonstrate that probiotics, prebiotics, and dietary interventions targeting the gut microbiota can modulate systemic inflammation and reduce uremic toxin levels, offering therapeutic potential. Understanding the bidirectional signaling within the gut-brain-kidney axis opens avenues for novel biomarkers and interventions in CKD management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, People's Hospital of Liyang, Liyang, China.
- School of Medicine, Jiangsu University, Zhenjiang, China.
- Danyang Hospital of Traditional Chinese Medicine, Danyang, China.
- Department of Microbiology, Faculty of Biological Sciences, University of Nigeria, Nsukka, Nigeria.
- Department of Urology, People's Hospital of Liyang, Liyang, China.
- Institute of Digestive Diseases, Jiangsu University, Zhenjiang, China.
Zitieren
APA
Zhu, J., Fu, Y., Olovo, C. V., Xu, J., Wu, Q., Wei, W., Jiang, K., & Zheng, X. (2025). The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1535356
Vancouver
Zhu J, Fu Y, Olovo CV, Xu J, Wu Q, Wei W, et al. The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1535356
BibTeX
@article{Zhu2025,
author = {Zhu, Jue and Fu, Yutong and Olovo, Chinasa Valerie and Xu, Jianguo and Wu, Qian and Wei, Wei and Jiang, Ke and Zheng, Xueming},
title = {The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1535356}
}
EUVIMED